INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 201 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2019. The put-call ratio across all filers is 1.09 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $125,619 | -73.0% | 11,358 | -67.2% | 0.00% | -100.0% |
| Q1 2023 | $464,638 | -12.3% | 34,597 | -19.2% | 0.00% | 0.0% |
| Q4 2022 | $529,597 | -80.9% | 42,813 | -36.7% | 0.00% | -87.5% |
| Q3 2020 | $2,769,000 | -23.3% | 67,609 | -11.2% | 0.01% | -27.3% |
| Q2 2020 | $3,611,000 | +1194.3% | 76,107 | +1479.0% | 0.01% | +1000.0% |
| Q1 2020 | $279,000 | -76.6% | 4,820 | -49.8% | 0.00% | -75.0% |
| Q4 2019 | $1,194,000 | +116.3% | 9,600 | +10.4% | 0.00% | +300.0% |
| Q3 2019 | $552,000 | +11.1% | 8,697 | +33.7% | 0.00% | -50.0% |
| Q2 2019 | $497,000 | +34.3% | 6,505 | +85.6% | 0.00% | +100.0% |
| Q1 2019 | $370,000 | +825.0% | 3,505 | +639.5% | 0.00% | – |
| Q4 2018 | $40,000 | +100.0% | 474 | +185.5% | 0.00% | – |
| Q3 2018 | $20,000 | -68.3% | 166 | -77.7% | 0.00% | – |
| Q2 2018 | $63,000 | +53.7% | 746 | +10.7% | 0.00% | – |
| Q1 2018 | $41,000 | +20.6% | 674 | +15.6% | 0.00% | – |
| Q4 2017 | $34,000 | -12.8% | 583 | -12.7% | 0.00% | – |
| Q3 2017 | $39,000 | -53.0% | 668 | -2.2% | 0.00% | – |
| Q2 2017 | $83,000 | +144.1% | 683 | +125.4% | 0.00% | – |
| Q1 2017 | $34,000 | +183.3% | 303 | +185.8% | 0.00% | – |
| Q4 2016 | $12,000 | -25.0% | 106 | +14.0% | 0.00% | – |
| Q3 2016 | $16,000 | +166.7% | 93 | +102.2% | 0.00% | – |
| Q2 2016 | $6,000 | +100.0% | 46 | +91.7% | 0.00% | – |
| Q1 2016 | $3,000 | -92.1% | 24 | -90.7% | 0.00% | – |
| Q4 2015 | $38,000 | -89.8% | 259 | -88.5% | 0.00% | -100.0% |
| Q3 2015 | $372,000 | -57.9% | 2,247 | -38.6% | 0.00% | -62.5% |
| Q2 2015 | $883,000 | -61.5% | 3,660 | -55.0% | 0.01% | -60.0% |
| Q1 2015 | $2,293,000 | +246.4% | 8,128 | +91.6% | 0.02% | +233.3% |
| Q4 2014 | $662,000 | – | 4,243 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 635,300 | $39,083,000 | 9.04% |
| Senvest Management, LLC | 1,152,032 | $70,873,000 | 5.40% |
| Melqart Asset Management (UK) Ltd | 298,200 | $18,345,000 | 2.20% |
| Elk Creek Partners, LLC | 348,454 | $21,437,000 | 1.25% |
| ALTRINSIC GLOBAL ADVISORS LLC | 375,223 | $23,084,000 | 0.93% |
| BB BIOTECH AG | 545,719 | $33,573,000 | 0.93% |
| Virtus ETF Advisers LLC | 14,681 | $903,000 | 0.78% |
| Opus Point Partners Management, LLC | 4,496 | $277,000 | 0.54% |
| Spark Investment Management LLC | 136,500 | $8,397,000 | 0.54% |
| Regal Investment Advisors LLC | 29,511 | $1,816,000 | 0.40% |